1600. An Optimal Respiratory Syncytial Virus (RSV) Treatment in Lung Transplant Recipients: Oral Ribavirin, Inhaled Ribavirin, or Conservative Approach

BACKGROUND: Respiratory syncytial virus (RSV) is a common community acquired infection in lung transplant recipients (LTRs). The mortality in RSV-infected LTRs has been reported as 10–20% despite antiviral therapy; however, there is no consensus regarding treatment given limited data. METHODS: A ret...

Descripción completa

Detalles Bibliográficos
Autores principales: Permpalung, Nitipong, Thaniyavarn, Tany, Saullo, Jennifer, Arif, Sana, Miller, Rachel, Reynolds, John, Alexander, Barbara D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253796/
http://dx.doi.org/10.1093/ofid/ofy210.1428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253796/
http://dx.doi.org/10.1093/ofid/ofy210.1428

Ejemplares similares